Sort
23,748 grants matching “melanoma”
Basal Cell Carcinoma:Molecular Pathogenesis &Prevention
$344,382Columbia University Health Sciences · R01 · FY2005 · CA
Basal Cell Carcinoma:Molecular Pathogenesis &Prevention
$344,382Columbia University Health Sciences · R01 · FY2004 · CA
Basal Cell Carcinoma:Molecular Pathogenesis &Prevention
$344,382Columbia University Health Sciences · R01 · FY2003 · CA
Components of Translation in Signal Transduction
$344,339Paul R Schimmel · Scripps Research Institute, The · R01 · FY2012 · CA
INITIATING THE ADAPTIVE IMMUNE RESPONSE TO CANCER
$344,323Per H. Basse · University Of Pittsburgh At Pittsburgh · P01 · FY2007 · CA
Biology Core
$344,322Meenhard Herlyn · Wistar Institute · P01 · FY2019 · CA
BIGDATA: Collaborative Research: F: Big Data, It's Not So Big: Exploiting Low-Dimensional Geometry for Learning and Inference
$344,319Lizhen Lin · University Of Texas At Austin · · FY2015 · CSE
ERK Signaling in Inflammatory Bone Loss
$344,282Francis Young-In Lee · Columbia University Health Sciences · R01 · FY2011 · AR
ERK Signaling in Inflammatory Bone Loss
$344,282Francis Young-In Lee · Columbia University Health Sciences · R01 · FY2012 · AR
The Functional Role of GRM3 in Colon Cancer
$344,269Jing Wang · University Of Nebraska Medical Center · R01 · FY2017 · CA
Optimization of Autophagy Inhibition as a Clinical Target for Brain Tumors
$344,265Jean Marie Mulcahy Levy · University Of Colorado Denver · R01 · FY2020 · NS
Optimization of Autophagy Inhibition as a Clinical Target for Brain Tumors
$344,265Jean Marie Mulcahy Levy · University Of Colorado Denver · R01 · FY2021 · NS
Phase II trial of 17-AAG in melanoma patients
$344,232Paul B Chapman · Sloan-Kettering Inst Can Research · R21 · FY2007 · CA
Development of FISH Molecular Diagnostics to support Clinical Trials at NCI
$344,228Svetlana Pack · Division Of Basic Sciences - Nci · ZID · FY2018 · CA
Large heat shock proteins and their role in cancer therapy
$344,200John R. Subjeck · Roswell Park Cancer Institute Corp · R01 · FY2016 · CA
Targeting Oncogenic BRAF And PI3'-Kinase Signaling For Melanoma Therapy
$344,200Martin McMahon · University Of Utah · R01 · FY2017 · CA
Vesicular stomatitis VSVrp30 selectively destroys human metastatic melanoma
$344,191Anthony N Van Den Pol · Yale University · R01 · FY2012 · CA
Access, Utilization and Outcomes of Cancer Services in the Era of Telemedicine
$344,165Tracy Onega · University Of Utah · R01 · FY2024 · CA
Biomarkers to Guide Treatment and Improve Survival in Oral/Oropharyngeal Cancer
$344,149Thomas E. Carey · University Of Michigan At Ann Arbor · R01 · FY2010 · DE
Role of HOS in Cell Transformation and Apoptosis
$344,138Serge Y Fuchs · University Of Pennsylvania · R01 · FY2020 · CA
Nuclear Accumulation of D-type Cyclins and Oncogenesis
$344,138J. Alan Diehl · Case Western Reserve University · R01 · FY2021 · CA
Role of HOS in Cell Transformation and Apoptosis
$344,138Serge Y Fuchs · University Of Pennsylvania · R01 · FY2018 · CA
Role of HOS in Cell Transformation and Apoptosis
$344,138Serge Y Fuchs · University Of Pennsylvania · R01 · FY2017 · CA
Role of HOS in Cell Transformation and Apoptosis
$344,138Serge Y Fuchs · University Of Pennsylvania · R01 · FY2021 · CA
Topical Micronutrient Delivery System
$344,127Niadyne, Inc. · R44 · FY2005 · CA